Cancer Treatment
Findings from the United States, Belgium and Japan describe new data in cancer treatment research
Published in Vaccine Weekly, August 16th, 2006
Study 1: Tumor autoantigens identified on protein microarrays can break tolerance during immunotherapy.
"Cancer patients develop antitumor immune responses, both humoral and cellular, against antigens expressed by their tumors. Low-throughput antigen cloning has been used to identify a number of immunogenic tumor antigens, but this process has limited utility for diagnostics or therapeutic vaccines," according to scientists in the United States.
"A novel approach to the identification of diagnostic antigens that utilizes a combination...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-08-16)
More Articles from Vaccine Weekly
- Avian Influenza Vaccine
Reverse-genetics-produced H5N1 bird flu vaccine protects ferrets - Candidiasis Vaccine
Vaccines show promise against disseminated and mucosal candidiasis - Chickenpox Vaccine
Live varicella vaccine benefits HIV-infected children with depressed CD4+ T cell counts - Polio Vaccine
Inactivated poliovirus vaccine derived from Sabin strains has been developed - Polio Vaccine
Worldwide oral polio vaccine cessation strategy is presented - Adenovirus Pathogenesis
Adenovirus type 2 and type 5 E1A genes are expressed at different levels - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
